Blue Sky Capital Consultants Group’s Moderna MRNA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$451K	Buy	16,354 +1,235	+8%	+$34.1K	0.23%	42
2025 Q1	$429K	Buy	15,119 +556	+4%	+$15.8K	0.28%	41
2024 Q4	$606K	Buy	+14,563	New	+$606K	0.36%	38